Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02619864
Title mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications

glioblastoma

Therapies

Vistusertib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.